The proportion of patients with low grade was higher in the tumors< 3 cm group than in the tumors≥ 3 cm group (P = 0.011), but not with HER-2 (P = 0.402) or pathologic stage (P = 0.089). The gene discussed is ERBB2; the disease is neoplasm.